Exhibit 107
Calculation of Filing Fee Tables
S-1
(Form Type)
MDNA Life Sciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed
| Maximum Aggregate Offering Price | Fee Rate | Amount Registration | Carry Forward Form Type | Carry Forward File Number | Carry date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||||
Equity | Common Stock (1) | 457(a) | 2,415,000 (3) | $ | 6.00 | $ | 14,490,000 | $ | 0.0001102 | $ | 1,596.80 | |||||||||||||||||||||||||||||||||
Equity | Representative’s warrants to purchase Common Stock (5) | 457(g) | 72,450 (4) | — | — | — | ||||||||||||||||||||||||||||||||||||||
Equity | Common Stock issuable upon exercise of the Representative’s warrants (1)(6) | 457(g) | 72,450 (4) | $ | 543,375 | $ | 0.0001102 | $ | 59.88 | |||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
Total Offering Amounts | 15,033,375 | $ | 1,656.68 | |||||||||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | $ | 2,280.68 | ||||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | 0 |
(1) | Pursuant to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares of Common Stock as may from time to time become issuable by reason of stock splits, distributions, recapitalizations, or other similar transactions. |
(2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(a) under the Securities Act. |
(3) | Includes 315,000 shares of common stock which the underwriters have the option to purchase to cover over-allotments. |
(4) | Includes 9,450 shares of common stock which the underwriters have the option to purchase to cover over-allotments. |
(5) | No fee required pursuant to Rule 457(g). |
(6) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The representative’s warrants are exercisable at a per share exercise price equal to 125% of the public offering price. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the representative’s warrants is equal to 125% of $434,700 (which is 3% of $14,490,000). |